Embryonic chimeras with human pluripotent stem cells

Alejandro De Los Angeles, Masahiro Sakurai, Jun Wu

Research output: Chapter in Book/Report/Conference proceedingChapter

Abstract

Human pluripotent stem (PS) cells can be isolated from preimplantation embryos or by reprogramming of somatic cells or germline progenitors. Human PS cells are considered the “holy grail” of regenerative medicine because they have the potential to form all cell types of the adult body. Because of their similarity to humans, nonhuman primate (NHP) PS cells are also important models for studying human biology and disease, as well as for developing therapeutic strategies and test bed for cell replacement therapy. This chapter describes adjusted methods for cultivation of PS cells from different primate species, including African green monkey, rhesus monkey, chimpanzee, and human. Supplementation of E8 medium and inhibitors of the Tankyrase and GSK3 kinases to various primate PS cell media reduce line-dependent predisposition for spontaneous differentiation in conventional PS cell cultures. We provide methods for basic characterization of primate PS cell lines, which include immunostaining for pluripotency markers such as OCT4 and TRA-1-60, as well as in vivo teratoma formation assay. We provide methods for generating alternative PS cells including region-selective primed PS cells, two different versions of naïve-like cells, and recently reported extended pluripotent stem (EPS) cells. These derivations are achieved by acclimation of conventional PS cells to target media, episomal reprogramming of somatic cells, or resetting conventional PS cells to a naïve-like state by overexpression of KLF2 and NANOG. We also provide methods for isolation of PS cells from human blastocysts. We describe how to generate interspecies primate-mouse chimeras at the blastocyst and postimplantation embryo stages. Systematic evaluation of the chimeric competency of human and primate PS cells will aid in efforts to overcome species barriers and achieve higher grade chimerism in postimplantation conceptuses that could enable organ-specific enrichment of human xenogeneic PS cell derivatives in large animals such as pigs and sheep.

Original languageEnglish (US)
Title of host publicationMethods in Molecular Biology
PublisherHumana Press Inc.
Pages125-151
Number of pages27
DOIs
StatePublished - Jan 1 2019

Publication series

NameMethods in Molecular Biology
Volume2005
ISSN (Print)1064-3745
ISSN (Electronic)1940-6029

Fingerprint

Pluripotent Stem Cells
Primates
Blastocyst
Tankyrases
Cercopithecus aethiops
Chimerism
Regenerative Medicine
Pan troglodytes
Acclimatization
Teratoma
Cell- and Tissue-Based Therapy
Macaca mulatta

Keywords

  • 5iLAF
  • Embryonic stem cell
  • Extended pluripotent stem cells
  • FGF
  • GSK3
  • Human pluripotent stem cells
  • Induced pluripotent stem cell
  • Interspecies chimeras
  • KLF2
  • KLF4
  • LCDM
  • LIN28
  • LMYC
  • Monkey pluripotent stem cells
  • NANOG
  • Naïve-like pluripotent stem cells
  • Nonhuman primates
  • OCT4
  • p53
  • Pluripotent stem cells
  • Primate pluripotent stem cells
  • Primates
  • Primed pluripotent stem cells
  • Region-selective
  • Reprogramming
  • SOX2
  • t2iL
  • Tankyrase
  • TNKS1/2
  • WNT

ASJC Scopus subject areas

  • Molecular Biology
  • Genetics

Cite this

De Los Angeles, A., Sakurai, M., & Wu, J. (2019). Embryonic chimeras with human pluripotent stem cells. In Methods in Molecular Biology (pp. 125-151). (Methods in Molecular Biology; Vol. 2005). Humana Press Inc.. https://doi.org/10.1007/978-1-4939-9524-0_9

Embryonic chimeras with human pluripotent stem cells. / De Los Angeles, Alejandro; Sakurai, Masahiro; Wu, Jun.

Methods in Molecular Biology. Humana Press Inc., 2019. p. 125-151 (Methods in Molecular Biology; Vol. 2005).

Research output: Chapter in Book/Report/Conference proceedingChapter

De Los Angeles, A, Sakurai, M & Wu, J 2019, Embryonic chimeras with human pluripotent stem cells. in Methods in Molecular Biology. Methods in Molecular Biology, vol. 2005, Humana Press Inc., pp. 125-151. https://doi.org/10.1007/978-1-4939-9524-0_9
De Los Angeles A, Sakurai M, Wu J. Embryonic chimeras with human pluripotent stem cells. In Methods in Molecular Biology. Humana Press Inc. 2019. p. 125-151. (Methods in Molecular Biology). https://doi.org/10.1007/978-1-4939-9524-0_9
De Los Angeles, Alejandro ; Sakurai, Masahiro ; Wu, Jun. / Embryonic chimeras with human pluripotent stem cells. Methods in Molecular Biology. Humana Press Inc., 2019. pp. 125-151 (Methods in Molecular Biology).
@inbook{a95fd570a4ad49a48ce4e6ba6cc6599b,
title = "Embryonic chimeras with human pluripotent stem cells",
abstract = "Human pluripotent stem (PS) cells can be isolated from preimplantation embryos or by reprogramming of somatic cells or germline progenitors. Human PS cells are considered the “holy grail” of regenerative medicine because they have the potential to form all cell types of the adult body. Because of their similarity to humans, nonhuman primate (NHP) PS cells are also important models for studying human biology and disease, as well as for developing therapeutic strategies and test bed for cell replacement therapy. This chapter describes adjusted methods for cultivation of PS cells from different primate species, including African green monkey, rhesus monkey, chimpanzee, and human. Supplementation of E8 medium and inhibitors of the Tankyrase and GSK3 kinases to various primate PS cell media reduce line-dependent predisposition for spontaneous differentiation in conventional PS cell cultures. We provide methods for basic characterization of primate PS cell lines, which include immunostaining for pluripotency markers such as OCT4 and TRA-1-60, as well as in vivo teratoma formation assay. We provide methods for generating alternative PS cells including region-selective primed PS cells, two different versions of na{\"i}ve-like cells, and recently reported extended pluripotent stem (EPS) cells. These derivations are achieved by acclimation of conventional PS cells to target media, episomal reprogramming of somatic cells, or resetting conventional PS cells to a na{\"i}ve-like state by overexpression of KLF2 and NANOG. We also provide methods for isolation of PS cells from human blastocysts. We describe how to generate interspecies primate-mouse chimeras at the blastocyst and postimplantation embryo stages. Systematic evaluation of the chimeric competency of human and primate PS cells will aid in efforts to overcome species barriers and achieve higher grade chimerism in postimplantation conceptuses that could enable organ-specific enrichment of human xenogeneic PS cell derivatives in large animals such as pigs and sheep.",
keywords = "5iLAF, Embryonic stem cell, Extended pluripotent stem cells, FGF, GSK3, Human pluripotent stem cells, Induced pluripotent stem cell, Interspecies chimeras, KLF2, KLF4, LCDM, LIN28, LMYC, Monkey pluripotent stem cells, NANOG, Na{\"i}ve-like pluripotent stem cells, Nonhuman primates, OCT4, p53, Pluripotent stem cells, Primate pluripotent stem cells, Primates, Primed pluripotent stem cells, Region-selective, Reprogramming, SOX2, t2iL, Tankyrase, TNKS1/2, WNT",
author = "{De Los Angeles}, Alejandro and Masahiro Sakurai and Jun Wu",
year = "2019",
month = "1",
day = "1",
doi = "10.1007/978-1-4939-9524-0_9",
language = "English (US)",
series = "Methods in Molecular Biology",
publisher = "Humana Press Inc.",
pages = "125--151",
booktitle = "Methods in Molecular Biology",

}

TY - CHAP

T1 - Embryonic chimeras with human pluripotent stem cells

AU - De Los Angeles, Alejandro

AU - Sakurai, Masahiro

AU - Wu, Jun

PY - 2019/1/1

Y1 - 2019/1/1

N2 - Human pluripotent stem (PS) cells can be isolated from preimplantation embryos or by reprogramming of somatic cells or germline progenitors. Human PS cells are considered the “holy grail” of regenerative medicine because they have the potential to form all cell types of the adult body. Because of their similarity to humans, nonhuman primate (NHP) PS cells are also important models for studying human biology and disease, as well as for developing therapeutic strategies and test bed for cell replacement therapy. This chapter describes adjusted methods for cultivation of PS cells from different primate species, including African green monkey, rhesus monkey, chimpanzee, and human. Supplementation of E8 medium and inhibitors of the Tankyrase and GSK3 kinases to various primate PS cell media reduce line-dependent predisposition for spontaneous differentiation in conventional PS cell cultures. We provide methods for basic characterization of primate PS cell lines, which include immunostaining for pluripotency markers such as OCT4 and TRA-1-60, as well as in vivo teratoma formation assay. We provide methods for generating alternative PS cells including region-selective primed PS cells, two different versions of naïve-like cells, and recently reported extended pluripotent stem (EPS) cells. These derivations are achieved by acclimation of conventional PS cells to target media, episomal reprogramming of somatic cells, or resetting conventional PS cells to a naïve-like state by overexpression of KLF2 and NANOG. We also provide methods for isolation of PS cells from human blastocysts. We describe how to generate interspecies primate-mouse chimeras at the blastocyst and postimplantation embryo stages. Systematic evaluation of the chimeric competency of human and primate PS cells will aid in efforts to overcome species barriers and achieve higher grade chimerism in postimplantation conceptuses that could enable organ-specific enrichment of human xenogeneic PS cell derivatives in large animals such as pigs and sheep.

AB - Human pluripotent stem (PS) cells can be isolated from preimplantation embryos or by reprogramming of somatic cells or germline progenitors. Human PS cells are considered the “holy grail” of regenerative medicine because they have the potential to form all cell types of the adult body. Because of their similarity to humans, nonhuman primate (NHP) PS cells are also important models for studying human biology and disease, as well as for developing therapeutic strategies and test bed for cell replacement therapy. This chapter describes adjusted methods for cultivation of PS cells from different primate species, including African green monkey, rhesus monkey, chimpanzee, and human. Supplementation of E8 medium and inhibitors of the Tankyrase and GSK3 kinases to various primate PS cell media reduce line-dependent predisposition for spontaneous differentiation in conventional PS cell cultures. We provide methods for basic characterization of primate PS cell lines, which include immunostaining for pluripotency markers such as OCT4 and TRA-1-60, as well as in vivo teratoma formation assay. We provide methods for generating alternative PS cells including region-selective primed PS cells, two different versions of naïve-like cells, and recently reported extended pluripotent stem (EPS) cells. These derivations are achieved by acclimation of conventional PS cells to target media, episomal reprogramming of somatic cells, or resetting conventional PS cells to a naïve-like state by overexpression of KLF2 and NANOG. We also provide methods for isolation of PS cells from human blastocysts. We describe how to generate interspecies primate-mouse chimeras at the blastocyst and postimplantation embryo stages. Systematic evaluation of the chimeric competency of human and primate PS cells will aid in efforts to overcome species barriers and achieve higher grade chimerism in postimplantation conceptuses that could enable organ-specific enrichment of human xenogeneic PS cell derivatives in large animals such as pigs and sheep.

KW - 5iLAF

KW - Embryonic stem cell

KW - Extended pluripotent stem cells

KW - FGF

KW - GSK3

KW - Human pluripotent stem cells

KW - Induced pluripotent stem cell

KW - Interspecies chimeras

KW - KLF2

KW - KLF4

KW - LCDM

KW - LIN28

KW - LMYC

KW - Monkey pluripotent stem cells

KW - NANOG

KW - Naïve-like pluripotent stem cells

KW - Nonhuman primates

KW - OCT4

KW - p53

KW - Pluripotent stem cells

KW - Primate pluripotent stem cells

KW - Primates

KW - Primed pluripotent stem cells

KW - Region-selective

KW - Reprogramming

KW - SOX2

KW - t2iL

KW - Tankyrase

KW - TNKS1/2

KW - WNT

UR - http://www.scopus.com/inward/record.url?scp=85067086707&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85067086707&partnerID=8YFLogxK

U2 - 10.1007/978-1-4939-9524-0_9

DO - 10.1007/978-1-4939-9524-0_9

M3 - Chapter

C2 - 31175650

AN - SCOPUS:85067086707

T3 - Methods in Molecular Biology

SP - 125

EP - 151

BT - Methods in Molecular Biology

PB - Humana Press Inc.

ER -